Top

Published in:

01-06-2020 | Surgery | Letter to the Editor

Tako-tsubo syndrome after intraperitoneal hyperthermic chemotherapy (HIPEC) with cisplatin: an unusual complication of cytoreductive surgery plus HIPEC

Authors: Alida González-Gil, Álvaro Jesús Gómez-Ruiz, José Gil-Martínez, Elena Gil-Gómez, Luis Falcón-Araña, Pedro Antonio Cascales-Campos

Published in: Clinical & Experimental Metastasis | Issue 3/2020

Excerpt

Dear Sir …

Pelliccia F, Kaski JC, Crea F et al (2017) Pathophysiology of Takotsubo syndrome. Circulation 135:2426–2441CrossRef

Pizzino G, Bitto A, Crea P et al (2017) Takotsubo syndrome and estrogen receptor genes: partners in crime? J Cardiovasc Med 18:268–276CrossRef

Saner FH, Plicht B, Treckmann J et al (2010) Tako-tsubo syndrome as a rare cause of cardiac failure in liver transplantation. Liver Int 30(1):159–160. https://doi.org/10.1111/j.1478-3231.2009.02062.x CrossRefPubMed

Kido K, Guglin M (2017) Drug-induced Takotsubo cardiomyopathy. J Cardiovasc Pharmacol Ther 22(6):552–563. https://doi.org/10.1177/1074248417708618 CrossRefPubMed

Madeddu C, Deidda M, Piras A et al (2016) Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy. J Cardiovasc Med 17:e12–e18. https://doi.org/10.2459/jcm.0000000000000376 CrossRef

Title: Tako-tsubo syndrome after intraperitoneal hyperthermic chemotherapy (HIPEC) with cisplatin: an unusual complication of cytoreductive surgery plus HIPEC
Authors: Alida González-Gil
Álvaro Jesús Gómez-Ruiz
José Gil-Martínez
Elena Gil-Gómez
Luis Falcón-Araña
Pedro Antonio Cascales-Campos
Publication date: 01-06-2020
Publisher: Springer Netherlands
Keywords: Surgery
Peritoneal Cancer
Peritoneal Carcinomatosis
Cytostatic Therapy
Published in: Clinical & Experimental Metastasis / Issue 3/2020
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI: https://doi.org/10.1007/s10585-020-10034-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2020

A study on different therapies and prognosis-related factors for brain metastases in lung adenocarcinoma patients with driver mutation

Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study

Astrocytic IGFBP2 and CHI3L1 in cerebrospinal fluid drive cortical metastasis of HER2+breast cancer

Tumor shedding and metastatic progression after tumor excision in patient-derived orthotopic xenograft models of triple-negative breast cancer

Laser interstitial thermal therapy for in-field recurrence of brain metastasis after stereotactic radiosurgery: does treatment with LITT prevent a neurologic death?

Keynote webinar | Spotlight on antibody–drug conjugates in cancer